Document Classification

Section Type: RESULTS

Text: The clinical effectiveness rate of GRI4, TBF2, and TBF4 were 100 % (95 % CI-confidence interval : 82-100 %), 96. 3 % (95 % CI : 81-100 %), and 100 % (95 % CI : 85-100 %), respectively, at week 8 and 100 % after 1 year for the 3 groups ; clinical cure rates were 84. 2 % (95 % CI : 77-99 %), 85. 2 % (95 % CI : 71-98 %), and 78. 3 % (95 % CI : 61-95 %), respectively, at week 8 and 100 % after 1 year for all agents ; mycological cure rates were 100 % (95 % CI : 74-100 %), 95. 0 % (95 % CI : 74-100 %), and 94. 1 % (95 % CI : 50-93 %) at week 8 and 100 % after 1 year for the 3 groups.